Shares of Faron Pharmaceuticals Oy (LON:FARN – Get Free Report) crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 181.67 ($2.32) and traded as high as GBX 183 ($2.34). Faron Pharmaceuticals Oy shares last traded at GBX 173 ($2.21), with a volume of 122,619 shares trading hands.
Faron Pharmaceuticals Oy Stock Performance
The stock has a market cap of £232.26 million, a price-to-earnings ratio of -4.63 and a beta of 0.36. The company’s fifty day simple moving average is GBX 181.67 and its two-hundred day simple moving average is GBX 186.49. The company has a debt-to-equity ratio of 922.55, a current ratio of 1.45 and a quick ratio of 1.09.
Faron Pharmaceuticals Oy Company Profile
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Read More
- Five stocks we like better than Faron Pharmaceuticals Oy
- Dividend Payout Ratio Calculator
- GitLab: Get In While It’s Down—Big Rebound Ahead
- Trading Halts Explained
- Tesla Stock: Finding a Bottom May Take Time
- What is a Stock Market Index and How Do You Use Them?
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
